Stock Market

For portfolio exposure to the data analytics, cybersecurity and artificial intelligence (AI) industries, you may be considering Palantir Technologies (NYSE:PLTR) stock right now. That’s understandable, but be careful. Investing in Palantir during a time of AI-market exuberance may be a costly mistake.  Don’t get the wrong idea. It could be a great idea to buy Palantir stock
0 Comments
Can Apple (NASDAQ:AAPL) stock have a “magnificent” performance this year, like it did in 2023? Apple’s investors should have realistic expectations on Wall Street. Despite being a large company, Apple still faces uncertainty in certain areas. We’ll address Apple’s challenges in a moment. If you already own Apple stock, you’ll likely want to continue holding or possibly
0 Comments
Marathon Digital (MARA) stock has faced a challenging start to the year, with shares dropping more than 20%. Some of this move can certainly be tied to Bitcoin’s (BTC-USD) performance, especially considering the high expectations for this token following the SEC’s approval of spot ETFs. Indeed, Bitcoin prices directly affect Marathon’s valuation, because Marathon’s entire
0 Comments
The positive future performance of the economy hinges on addressing concerns about businesses’ adaptation to post-pandemic dynamics. Efforts include renegotiating discounts with manufacturers as retailers seek to regain bargaining power. The effectiveness of these strategies and consumers’ response to potential price increases will play a pivotal role in fostering economic growth. The current economic performance
0 Comments
Ahead of Tesla’s (NASDAQ:TSLA) upcoming quarterly earnings release, the TSLA stock sell-off has continued. The market has soured on electric vehicle plays, and not only smaller, more speculative names. Even this established and profitable EV market leader has become the victim of shifting market sentiment. Worse yet, there is a strong chance that this sell-off
0 Comments
Finding millionaire-maker stocks could be likened to finding a needle in a haystack! The upcoming decade may be turbulent. Not only will we grapple with a building geopolitical tension globally. But also, worries stemming from climate change and economic malaise are pressing. It’s a sentiment that’s been a subject of concern, reflected from the ongoing
0 Comments
For many biotech stocks, price and performance hinges on the success of a drug in testing. This means most biotech companies rely on one market opportunity to succeed financially. Testing usually takes several years, with many different criteria to meet before applying for review by regulators. Even after successful tests, the survival of these stocks
0 Comments